Discover how phenotypic assay data can be used to uncover mechanisms of efficacy and toxicity. How knowledge frameworks such as adverse outcome pathway (AOP) and discovery program outcome pathway (DPOP) frameworks help connect molecular targets to clinical outcomes. How best to integrate information for program decision-making, clinical hypothesis generation and the design of mitigation strategies.

Related Posts